Related Experiment Video

Updated: Aug 30, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

New approaches to invasive fungal infections

Kieren A Marr1

  • 1Fred Hutchinson Cancer Research Center, University of Washington, Seatle, WA 98109, USA. kmarr@fhcrc.org

Current Opinion in Hematology
|October 18, 2003
PubMed

Insights

Recent advancements improve prevention, diagnosis, and treatment of invasive fungal infections, particularly for high-risk patients. This review evaluates new strategies to combat these challenging infections and reduce mortality.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Invasive fungal infections (IFIs) present significant challenges in prevention, diagnosis, and treatment.
  • High mortality rates are observed, especially in immunocompromised patients like those with prolonged neutropenia or severe graft-versus-host disease.
  • Despite challenges, recent progress offers new hope.

Purpose of the Study:

  • To review recent developments in understanding IFIs.
  • To evaluate novel diagnostic tests and antifungal therapies.
  • To explore updated strategies for preventing and treating IFIs.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of advancements in fungal immunology and epidemiology.
  • Assessment of new diagnostic tools and antifungal agents.

Main Results:

  • Significant progress in understanding the immune response to fungi.
  • Emergence of new diagnostic tests for earlier detection.
  • Development of novel antifungal drugs with improved efficacy.
  • Identification of evolving epidemiological trends in IFIs.

Conclusions:

  • New approaches offer improved prospects for managing IFIs.
  • Integrated strategies combining diagnostics, therapeutics, and prevention are crucial.
  • Continued research is vital to further reduce morbidity and mortality associated with IFIs.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...